Hyperbaric O2 Therapy Ltd SC548913 false 2023-11-01 2024-10-31 2024-10-31 The principal activity of the company is provision of access to a hyperbaric chamber. Digita Accounts Production Advanced 6.30.9574.0 true SC548913 2023-11-01 2024-10-31 SC548913 2024-10-31 SC548913 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2024-10-31 SC548913 core:RetainedEarningsAccumulatedLosses 2024-10-31 SC548913 core:ShareCapital 2024-10-31 SC548913 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 SC548913 core:OtherPropertyPlantEquipment 2024-10-31 SC548913 bus:SmallEntities 2023-11-01 2024-10-31 SC548913 bus:AuditExemptWithAccountantsReport 2023-11-01 2024-10-31 SC548913 bus:FilletedAccounts 2023-11-01 2024-10-31 SC548913 bus:SmallCompaniesRegimeForAccounts 2023-11-01 2024-10-31 SC548913 bus:RegisteredOffice 2023-11-01 2024-10-31 SC548913 bus:Director2 2023-11-01 2024-10-31 SC548913 bus:Director3 2023-11-01 2024-10-31 SC548913 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2023-11-01 2024-10-31 SC548913 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 SC548913 bus:Agent1 2023-11-01 2024-10-31 SC548913 core:OtherPropertyPlantEquipment 2023-11-01 2024-10-31 SC548913 core:PlantMachinery 2023-11-01 2024-10-31 SC548913 core:OtherRelatedParties 2023-11-01 2024-10-31 SC548913 countries:Scotland 2023-11-01 2024-10-31 SC548913 2023-10-31 SC548913 core:OtherPropertyPlantEquipment 2023-10-31 SC548913 2022-11-01 2023-10-31 SC548913 2023-10-31 SC548913 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2023-10-31 SC548913 core:RetainedEarningsAccumulatedLosses 2023-10-31 SC548913 core:ShareCapital 2023-10-31 SC548913 core:CurrentFinancialInstruments core:WithinOneYear 2023-10-31 SC548913 core:OtherPropertyPlantEquipment 2023-10-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: SC548913

Hyperbaric O2 Therapy Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 October 2024

 

Hyperbaric O2 Therapy Ltd

Contents

Company Information

1

Accountants' Report

2

Balance Sheet

3

Notes to the Unaudited Financial Statements

4 to 7

 

Hyperbaric O2 Therapy Ltd

Company Information

Directors

Mr D S J B McCann

Dr M A McCann

Registered office

Castle Craig
Blyth Bridge
West Linton
Peeblesshire
EH46 7DH

Accountants

Deans Accountants And Business Advisors Ltd 27 North Bridge Street
Hawick
Scottish Borders
TD9 9BD

 

DEANS

Chartered Accountants

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Hyperbaric O2 Therapy Ltd for the Year Ended 31 October 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Hyperbaric O2 Therapy Ltd for the year ended 31 October 2024 as set out on pages 3 to 7 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants of Scotland (ICAS), we are subject to its ethical and other professional requirements which are detailed at http://www.icas.com/ethics/icas-code-of-ethics.

This report is made solely to the Board of Directors of Hyperbaric O2 Therapy Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Hyperbaric O2 Therapy Ltd and state those matters that we have agreed to state to the Board of Directors of Hyperbaric O2 Therapy Ltd, as a body, in this report in accordance with ICAS guidance (www.icas.com/accountsprep/guidance). To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Hyperbaric O2 Therapy Ltd and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Hyperbaric O2 Therapy Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Hyperbaric O2 Therapy Ltd. You consider that Hyperbaric O2 Therapy Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Hyperbaric O2 Therapy Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Deans Accountants And Business Advisors Ltd
27 North Bridge Street
Hawick
Scottish Borders
TD9 9BD

21 July 2025

 

Hyperbaric O2 Therapy Ltd

(Registration number: SC548913)
Balance Sheet as at 31 October 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

-

25,000

Current assets

 

Cash at bank and in hand

 

5,118

3,425

Creditors: Amounts falling due within one year

5

(27,480)

(67,480)

Net current liabilities

 

(22,362)

(64,055)

Net liabilities

 

(22,362)

(39,055)

Capital and reserves

 

Called up share capital

6

100

100

Retained earnings

(22,462)

(39,155)

Shareholders' deficit

 

(22,362)

(39,055)

For the financial year ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 21 July 2025 and signed on its behalf by:
 

.........................................
Mr D S J B McCann
Director

   
     
 

Hyperbaric O2 Therapy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2024

1

General information

The company is a private company limited by share capital, incorporated in Scotland.

The address of its registered office is:
Castle Craig
Blyth Bridge
West Linton
Peeblesshire
EH46 7DH
Scotland

These financial statements were authorised for issue by the Board on 21 July 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The company is not directly impacted by Brexit.

The company has suffered financially from the pandemic. Where appropriate, government support in the forms of grants and loans were used to mitigate the impact of lockdowns etc. The directors will continue to assess the impact of the pandemic and make decisions accordingly.

The financial statements are presented in Sterling (£) and rounded to the nearest £0.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant & machinery

not depreciated

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Hyperbaric O2 Therapy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2024

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Financial instruments

Classification
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of it’s liabilities.
 Recognition and measurement
Where shares are issued, any component that creates, a financial liability of the company is presented as a liability in the balance sheet. The corresponding dividends relating to the liability component are charged as an interest expenses in the profit and loss account.
 Impairment
At the end of each reporting period financial instruments measured at fair value are assessed for objective evidence of impairment. The impairment loss is recognised in the profit and loss account.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2023 - 3).

 

Hyperbaric O2 Therapy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2024

4

Tangible assets

Other tangible assets
£

Total
£

Cost or valuation

At 1 November 2023

25,000

25,000

Disposals

(25,000)

(25,000)

At 31 October 2024

-

-

Depreciation

Carrying amount

At 31 October 2024

-

-

At 31 October 2023

25,000

25,000

5

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Accruals and deferred income

250

250

Other creditors

27,230

67,230

27,480

67,480

6

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

       
 

Hyperbaric O2 Therapy Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2024

7

Related party transactions

Summary of transactions with other related parties

Castle Craig Hospital Ltd
During the year transfers of £Nil were made into the company with deferred payment terms. This forms part of the total balance of £27,230 (2023: £42,230) in other creditors that is due to Castle Craig Hospital Limited. The directors of the company hold similar positions as directors within Castle Craig Hospital Ltd.

Hyper Baric Oxygen Treatment Trust
During the year no transfers were made to the company with deferred payment terms. This forms part of the total balance of £Nil (2023: £25,000) in other creditors that is due to Hyper Baric Oxygen Treatment Trust. The directors of the company hold similar positions as directors within Hyper Baric Oxyen Treatment Trust.